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ABSTRACT 23 
We used a murine model of acute, post-traumatic osteomyelitis to evaluate the virulence of 24 
two divergent Staphylococcus aureus clinical isolates (the USA300 strain LAC and USA200 25 
strain UAMS-1) and their isogenic sarA mutants. The results confirmed that both strains caused 26 
a comparable degree of the osteolysis and reactive new bone formation in the acute phase of 27 
osteomyelitis. Conditioned medium (CM) from stationary phase cultures of both strains was 28 
cytotoxic to established cell lines (MC3TC-E1 and RAW 264.7) and primary murine calvarial 29 
osteoblasts and bone marrow-derived osteoclasts. Both the cytotoxicity of CM and the reactive 30 
changes in bone were significantly reduced in the isogenic sarA mutants. These results confirm 31 
that sarA is required for the production and/or accumulation of extracellular virulence factors 32 
that limit osteoblast and osteoclast viability and thereby promote bone destruction and reactive 33 
bone formation during the acute phase of S. aureus osteomyelitis. Proteomic analysis confirmed 34 
reduced accumulation of multiple extracellular proteins in LAC and UAMS-1 sarA mutants. 35 
Included among these were the alpha class of phenol-soluble modulins (PSMs), which were 36 
previously implicated as important determinants of osteoblast cytotoxicity and bone destruction 37 
and repair processes in osteomyelitis. Mutation of the corresponding operon reduced the 38 
osteoblast and osteoclast cytotoxicity of CM from both UAMS-1 and LAC. It also significantly 39 
reduced both reactive bone formation and cortical bone destruction in LAC. However, this was 40 
not true in a UAMS-1 psmα mutant, thereby suggesting the involvement of additional virulence 41 
factors in such strains that remain to be identified.    42 
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INTRODUCTION 43 
Staphylococcus aureus is a highly versatile pathogen capable of causing a remarkable 44 
array of human infections. One of the most devastating of these is osteomyelitis, which is 45 
extremely difficult to eradicate without extensive and often repetitive surgical debridement (1). 46 
Indeed, it has been suggested that, as with cancer, “remission” is a more appropriate term than 47 
“cure” in the context of osteomyelitis (2). Several factors contribute to this therapeutic 48 
recalcitrance including the inability to diagnose the infection before it has progressed to a 49 
chronic stage in which the local vasculature is compromised, formation of a bacterial biofilm that 50 
limits the efficacy of both conventional antibiotics and host defenses, the emergence of 51 
phenotypic variants within the biofilm (persister cells and small-colony variants) that exhibit 52 
metabolic traits that limit their antibiotic susceptibility, and the ability of the pathogens involved, 53 
including S. aureus, to invade and replicate within host cells including osteoblasts (3-9). 54 
Collectively, these factors dictate that the clinical problem of osteomyelitis extends far beyond 55 
acquired resistance and the increasingly limited availability of antibiotics.  56 
Our laboratory has placed a major emphasis on overcoming this problem by exploring 57 
alternative means for early diagnosis (3, 10), developing improved methods for localized 58 
antibiotic delivery for the prevention and treatment of infection (11-14), and identifying the 59 
bacterial factors that contribute to the prominence of S. aureus as an orthopaedic pathogen. 60 
With respect to the latter, our studies have led us to place a primary emphasis on the 61 
staphylococcal accessory regulator (sarA), mutation of which limits biofilm formation to a greater 62 
degree than mutation of any other regulatory locus we have examined (11, 15). The negative 63 
impact of mutating sarA on biofilm formation is also apparent in all S. aureus strains we have 64 
examined other than those with recognized regulatory defects (16, 17). Moreover, even in those 65 
cases in which a mutation enhanced biofilm formation, concomitant mutation of sarA reversed 66 
this effect (12, 15-17). We also confirmed that the limited ability of sarA mutants to form a 67 
biofilm can be correlated with increased susceptibility to diverse functional classes of antibiotic 68 
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in vivo (18, 19). Additionally, mutation of sarA limits the ability of S. aureus to persist in the 69 
bloodstream and cause secondary infections including hematogenous osteomyelitis (20, 21).  70 
Taken together, these results suggest that sarA is a viable and perhaps preferred 71 
regulatory target in the context of biofilm-associated infections including osteomyelitis. However, 72 
this conclusion must be interpreted with caution. For instance, under in vitro conditions, the 73 
relative impact of sarA vs. the saePQRS (saeRS) regulatory locus on biofilm formation was 74 
recently shown to be dependent on the medium used to carry out the biofilm assay (22). 75 
Moreover, mutation of saeRS in the USA300 strain LAC was shown to limit virulence in a 76 
murine model of post-traumatic osteomyelitis owing to the increased production of the 77 
extracellular protease aureolysin, which results in decreased accumulation of phenol-soluble 78 
modulins (PSMs) that would otherwise promote cytotoxicity of osteoblasts and bone destruction 79 
(23). A recent report also demonstrated that, under the hypoxic conditions encountered in bone, 80 
particularly as the infection progresses to a point that compromises the local blood supply, the 81 
srrAB regulatory locus plays a key role in S. aureus survival (24). Such results emphasize the 82 
complexity of the disease process in osteomyelitis and the fact that biofilm formation per se is 83 
not the only relevant consideration.  84 
In this respect it is important to note that the impact of mutating sarA has not been 85 
evaluated in the context of bone infection. It has been demonstrated that, at least under in vitro 86 
conditions, mutation of sarA results in a much greater increase in protease production than 87 
mutation of saeRS (12, 17), and that this can be correlated with reduced accumulation of 88 
multiple virulence factors including PSMs (20). Thus, it would be anticipated that mutation of 89 
sarA would also have a significant impact in this clinical context, but this has not been 90 
experimentally determined. Additionally, studies examining the role of different regulatory loci in 91 
a newly developed murine model of post-traumatic osteomyelitis have been limited to date to 92 
the USA300 strain LAC, which produces PSMs at high levels by comparison to many other 93 
strains of S. aureus (25-27). In this report, we address these issues by using this same murine 94 
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model to assess the relative virulence of two genetically and phenotypically divergent strains of 95 
S. aureus and their isogenic sarA and psm mutants.  96 
MATERIALS AND METHODS 97 
Bacterial strains and growth conditions. The S. aureus strains utilized in this study included 98 
a plasmid cured, erythromycin-sensitive derivative of the MRSA USA300 strain LAC (28), the 99 
USA200 MSSA osteomyelitis isolate UAMS-1 (29), and derivatives of each carrying mutations in 100 
sarA or the operon encoding alpha (α) PSMs. Mutants were generated by ɸ11-mediated 101 
transduction from mutants already on hand (19, 20, 23). Mutations in sarA and the alpha psm 102 
operon were genetically complemented using pSARA and pTX∆α as previously described (16, 103 
27). Strains were maintained at -80°C in tryptic soy broth (TSB) containing 25% (v/v) glycerol. 104 
For analysis, strains were cultured from cold storage by plating on tryptic soy agar (TSA) with 105 
the appropriate antibiotic selection. Antibiotics were used at the following concentrations: 106 
chloramphenicol (Cm; 10 µg ml-1), erythromycin (Erm; 10 µg ml-1), kanamycin (Kan; 50 µg ml-1) 107 
and neomycin (Neo; 50 µg/ml), and tetracycline (Tet; 5 µg ml-1). 108 
Preparation of conditioned medium. Stationary phase cultures were standardized to an 109 
optical density at 560 nm of 8.0. Cells were harvested by centrifugation and the supernatants 110 
filter sterilized. Cultured media was combined 1:1 with the appropriate cell culture media 111 
containing 10% fetal bovine serum (FBS) and added to cell monolayers for cytotoxicity assays.  112 
Cultivation of primary murine calvarial osteoblasts. Murine primary calvarial osteoblasts 113 
were obtained from 3-5 day-old C57BL/6 pups according to standard procedures (30) modified 114 
as follows: whole calvariae were dissected out (periosteum and endosteum were scraped off 115 
with a scalpel) and sequentially digested for 20 minutes at 37°C in alpha-MEM containing 0.1 116 
mg/ml collagenase P (Roche), 0.04% trypsin/EDTA, and penicillin/streptomycin (166 U/ml and 117 
166 µg/ml, respectively). The first 2 fractions of cells were discarded. Calvariae were further 118 
diced with sterile surgical scissors and digested in 1 ml of alpha-MEM with a double amount of 119 
collagenase and trypsin/EDTA for 1 hour at 37°C with vigorous shaking every 15-20 minutes. 120 
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Then 3.75 ml of alpha-MEM containing 15% FBS and penicillin/streptomycin was added. After 121 
24 hours, osteoblasts were washed with sterile PBS and expanded alpha-MEM containing 10% 122 
FBS, 2 mM glutamine, and penicillin and streptomycin (100 µg/ml and 100 µg/ml, respectively) 123 
for 2-4 days before passaging. Only early passaged osteoblasts grown in culture medium 124 
supplemented with 100 µg/ml of ascorbic acid were used for cytotoxicity assays. 125 
Cytotoxicity assay. Cytotoxicity with primary osteoblasts and established cell lines were 126 
done using the same methods. MC3T3-E1 and RAW 264.7 cells were obtained from the 127 
American Type Culture Collection (ATCC) and propagated according to ATCC 128 
recommendations. Cells were grown at 37°C and 5% CO2 with replacement of media every 2 or 129 
3 days. For cytotoxicity assays, cells were seeded into black clear bottom 96-well tissue culture 130 
grade plates at a density of 10,000 cells per well for MC3T3-E1 cells, 50,000 cells per well for 131 
RAW 264.7 cells or 10,000 cells per well for calvarial osteoblasts. After 24 hrs, growth media 132 
was removed and replaced with media containing a 1:1 ratio of cell culture complete growth 133 
media and S. aureus conditioned medium. Monolayers were incubated for an additional 24 hr 134 
prior to removal of media and assessment of cell viability using calcien-AM to stain live cells 135 
(ThermoFisher Scientific) according to the manufacturer’s specifications. An Omega FLUOstar 136 
microplate reader, (BMG Labtech), was used to determine the fluorescent intensity at 517 nm. 137 
Results of microtiter plate assays were confirmed through fluorescence microscopy.  138 
Cultivation and TRAP staining of primary osteoclasts. Whole bone marrow was extracted 139 
from tibia and femurs of one or two 8–10 week-old mice. Red blood cells were lysed in buffer 140 
(150 mM NH4Cl, 10 mM KNCO3, 0.1 mM EDTA, pH 7.4) for 5 minutes at room temperature. 5 X 141 
106 bone marrow cells were plated in a 100 mm petri-dish and cultured in α-10 medium (α-142 
MEM, 10% heat-inactivated FBS, 1 × PSG) containing 1/10 volume of CMG 14–12 (conditioned 143 
medium supernatant containing recombinant M-CSF at 1 µg/ml) for 4 to 5 days. Pre-osteoclasts 144 
and osteoclasts were generated by culturing bone marrow macrophages (BMMs) at a density of 145 
160/mm2 in 1/100 vol of CMG 14–12 culture supernatant and 100 ng/ml of recombinant RANKL. 146 
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To determine cell viability tartrate-resistant acid phosphatase (TRAP) staining was used to 147 
count viable cells. BMMs were cultured on 48-well tissue culture plate in α-10 medium with M-148 
CSF and RANKL for 4-5 days. After media replacement, cells were treated with S. aureus 149 
cultured supernatants diluted 1:1 in complete growth media. Cells were then fixed with 4% 150 
paraformaldehyde/phosphate buffered saline (PBS) and TRAP stained with NaK Tartrate and 151 
Napthol AS-BI phosphoric acid (Sigma-Aldrich). 152 
Murine model of acute post-traumatic osteomyelitis. This model was performed as 153 
previously described (23). Briefly, surgery was performed on the right hind limb of 8-10 week old 154 
female C57BL/6 mice. Prior to surgery, mice received 0.1 mg/kg buprenorphine via 155 
subcutaneous injection. Anesthesia was then maintained using isoflurane. The femur was 156 
exposed by blunt dissection, and a 1 mm unicortical bone defect was created at the lateral 157 
midshaft of the femur with a 21-gauge Precision Glide needle (Becton Dickinson). A bacterial 158 
inoculum of 1 X 105 colony-forming units (cfu) in 2 µl was delivered into the intramedullary 159 
canal. Muscle fasciae and skin were then closed with sutures, and mice allowed to recover from 160 
anesthesia. Infection was allowed to proceed for 14 days, at which time mice were euthanized 161 
and the right femur removed and subjected to microCT analysis. All experiments involving 162 
animals were reviewed and approved by the Institutional Animal Care and Use Committee of 163 
the University of Arkansas for Medical Sciences and were performed according to NIH 164 
guidelines, the Animal Welfare Act, and US Federal law. 165 
Microcomputed tomography. The analysis of cortical bone destruction and new bone 166 
formation was determined using microCT imaging with a Skyscan 1174 (Bruker) and scans 167 
analyzed using manufacturer’s analytical software. Briefly, axial images of each femur were 168 
acquired at a resolution of 6.7 µm at 50 kV, 800 µA through a 0.25 mm aluminum filter. Bones 169 
were visualized using a scout scan and then scanned in three sections as an oversize scan to 170 
image the entire femoral length. The volume of cortical bone was isolated in a semi-automated 171 
process as per manufacturer’s instructions. Briefly, cortical bone was isolated from soft tissue 172 
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and background by global thresholding (89 low, 255 high). The processes of opening, closing, 173 
dilation, erosin and despeckle were configured using the sham bones to separate the new bone 174 
from the existing cortical bone and task list created to apply the same process and values to all 175 
bones in the data set. After processing of the bones using the task list, volume of interest (VOI) 176 
was corrected by drawing inclusive or exclusive contours on the periosteal surface. Cortical 177 
bone destruction analysis consisted of 600 slices centered on the initial surgical bone defect. 178 
Destruction was determined by bone volume of infected bones subtracted from the average of 179 
sham bone volume. Reactive new bone formation was assessed by first isolating the region of 180 
interest (ROI) that only contained original cortical bone (as above). After cortical bone isolation 181 
new bone volume was determined subtracting original bone volume from total bone volume. All 182 
calculations were performed based on direct voxel counts. 183 
Proteomic analysis. The assessment of S. aureus secreted proteome of both parent strains 184 
and their isogenic sarA mutants was performed in triplicate as previously described (20). Briefly, 185 
SDS-PAGE lanes were divided into 20 slices and subjected to in-gel trypsin digestion. Gel slices 186 
were destained in 50% methanol, 100 mM ammonium bicarbonate, followed by reduction in 10 187 
mMTris[2-carboxyethyl]phosphine and alkylation in 50 mM iodoacetamide. Gel slices were then 188 
dehydrated in acetonitrile, followed by addition of 100 ng of sequencing grade porcine trypsin 189 
(Promega, Madison, WI) in 100 mM ammonium bicarbonate and incubation at 37°C for 12–16 h. 190 
Peptide products were then acidified in 0.1% formic acid (Fluka, Milwaukee, WI). Tryptic 191 
peptides were analyzed by high resolution tandem mass spectrometry with a Thermo LTQ 192 
Orbitrap Velos mass spectrometer coupled to a Waters nanoACQUITY LC system. Proteins 193 
were identified from MS/MS spectra by searching the UniprotKB USA300 (LAC) or MRSA252 194 
(UAMS-1) databases for the organism Staphylococcus aureus (2607 entries) using the Mascot 195 
search engine (Matrix Science, Boston, MA).  196 
Statistical analysis. The results of both in vitro and in vivo experiments were tested for 197 
statistical significance using the Student’s t test. Comparisons were made between the two 198 
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parent strains or between each parent strain and its appropriate isogenic mutant. P-values 199 
≤0.05 were considered statistically significant.  200 
RESULTS AND DISCUSSION 201 
A primary focus of our laboratory has been on developing alternative strategies that can be 202 
used to overcome the therapeutic recalcitrance of orthopaedic infections including osteomyelitis. 203 
Despite the current prominence of hypervirulent isolates of the USA300 clonal lineage (25), it is 204 
imperative that the genetic and phenotypic diversity of different S. aureus strains be taken into 205 
account in this regard. Based on this, we chose to focus on the USA300 methicillin-resistant 206 
strain LAC and the USA200, methicillin-sensitive isolate UAMS-1, which have been shown to be 207 
distinct by comparison to each other with respect to both gene content and overall 208 
transcriptional patterns (29, 31). Of note is the fact that LAC and many other USA300 isolates 209 
express the accessory gene regulator (agr) at high levels by comparison to strains like UAMS-1 210 
and consequently produce extracellular toxins, including phenol-soluble modulins (PSMs), at 211 
higher levels (25, 27). At the same time, UAMS-1 (ATCC 49230) has a proven clinical 212 
provenance in the specific context of osteomyelitis, having been isolated directly from the bone 213 
of a patient during surgical debridement (32). 214 
Thus, we used equivalent numbers (105 cfu) of LAC, UAMS-1, and their isogenic sarA 215 
mutants to infect mice via direct inoculation into the medullary canal via a unicortical defect (23). 216 
Femurs were harvested 14 days post infection and subjected to µCT analysis to assess cortical 217 
bone destruction and reactive new bone (callus) formation. Quantitative analysis was based on 218 
reconstructive evaluation of a series of images spanning from the prominence of the lessor 219 
trochanter to the distal femoral growth plate. This analysis confirmed that infection with either 220 
strain caused osteolysis at and around the site of inoculation and reactive new bone (callus) 221 
formation both proximally and distally to this site (Fig. 1). Both of these phenotypes were 222 
elevated in mice infected with LAC by comparison to those infected with UAMS-1, although 223 
these differences were not statistically significant (Fig. 2). 224 
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In LAC, mutation of sarA limited both the osteolysis and reactive new bone formation to a 225 
significant degree by comparison to the isogenic parent strain (Fig. 2). In UAMS-1, the impact of 226 
mutating sarA was statistically significant only in the context of reactive bone formation, with 227 
cortical bone destruction being reduced but not to a significant degree. However, these results 228 
must be interpreted with caution in that the surgical procedure itself involves the destruction of 229 
cortical bone to gain access to the intramedullary canal, thus complicating the analysis by 230 
comparison to that involving new bone formation.  231 
Nevertheless, these results suggest that the virulence factor(s) produced by S. aureus that 232 
contribute to bone remodeling in osteomyelitis are likely to be produced in greater amounts by 233 
LAC than UAMS-1 and that mutation of sarA limits the production and/or accumulation of these 234 
virulence factors in both strains. Thus, while mutation of sarA has been shown to limit biofilm 235 
formation both in vitro and in vivo to a degree that can be correlated with increased antibiotic 236 
susceptibility (15, 18, 33, 34), and to limit virulence in a murine model of bacteremia that can be 237 
correlated with a reduced capacity to cause hematogenous osteomyelitis (20, 21), this is the 238 
first demonstration that it also limits virulence in a relevant model of post-traumatic bone 239 
infection and, perhaps more importantly, that it does so in diverse clinical isolates.  240 
Bone is a highly dynamic physiological environment in which constant remodeling occurs in 241 
response to biomechanical stresses and hormonal influences (35, 36). This remodeling process 242 
is mediated by osteoblasts and osteoclasts, the first being responsible for new bone formation 243 
(ossification) and the second being responsible for bone resorption prior to osteoblast-mediated 244 
ossification. Osteocytes are terminally differentiated osteoblasts that become embedded within 245 
lacunae in the mineralized bone matrix; they extend long cytoplasmic processes through 246 
apertures of the lacunae that form a dense canalicular network inside the bone. They are the 247 
most abundant cell type in the adult skeleton and form an interconnected network that can 248 
coordinate the activity of osteoblasts and osteoclasts to facilitate bone repair and ultimately 249 
maintain its structural integrity (35, 36). Thus, disruption in the balance of osteoblast vs. 250 
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osteoclast function has the potential to compromise this integrity. For instance, bone destruction 251 
could result from increased osteoclast function or decreased osteoblast function. Conversely, 252 
new bone (callus) formation in the form of woven bone could result from increased osteoblast 253 
function or decreased osteoclast function.  254 
To investigate whether osteoblasts and osteoclasts are directly affected by the secreted 255 
products of S. aureus, we evaluated the extent to which conditioned media (CM) from LAC, 256 
UAMS-1, and their isogenic sarA mutants impact osteoblast and osteoclast viability. We chose 257 
to focus on CM based on a previous report demonstrating that the increased production of 258 
extracellular proteases in a LAC saeRS mutant limits the accumulation of important extracellular 259 
virulence factors that contribute to bone destruction and repair process (23), and our studies 260 
demonstrating that mutation of sarA results in a greater increase in protease production than 261 
mutation of saeRS (12, 17). We initially focused on the pre-osteoblast cell line MC3T3-E1 262 
because these cells have characteristics similar to primary calvarial osteoblasts and are derived 263 
from C57BL/6 mice, which is the same mouse strain used for our in vivo experiments. Similarly, 264 
we used the RAW 264.7 macrophage cell line as a surrogate for osteoclasts because they 265 
exhibit characteristics similar to those of bone marrow macrophages, the precursors of primary 266 
osteoclasts, but as an established cell line offer the advantage of ready accessibility and ease of 267 
manipulation.  268 
CM from LAC (Fig. 3) and UAMS-1 (Fig. 4) was cytotoxic for both MC3T3-E1 and RAW 269 
264.7 cells, and in both strains mutation of sarA limited this cytotoxicity.  This was also true 270 
when the experiments were repeated using primary calvarial osteoblasts (Fig. 5) and, as 271 
assessed based on the number of TRAP-positive multinucleated, primary bone marrow-derived 272 
osteoclasts (Fig. 6). When assessed using primary osteoclasts, CM from LAC appeared to be 273 
more cytotoxic for primary bone marrow-derived macrophages, although the difference did not 274 
reach statistical significance. The changes observed with each parent strain and their isogenic 275 
sarA mutants were consistent using both established cell lines and primary cells, which is 276 
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important given that cell lines are much easier to maintain and more experimentally amenable. 277 
More importantly, these results are also consistent with the hypothesis that there is a cause-278 
and-effect relationship between osteoblast and osteoclast cytotoxicity and bone destruction and 279 
repair processes in acute, post-traumatic osteomyelitis.  280 
Given the cytotoxicity of both LAC and UAMS-1 CM for osteoblasts and osteoclasts, and 281 
the impact of both strains on bone destruction and repair processes, we examined the 282 
exoprotein profiles of each strain and their isogenic sarA mutants by GeLC-MS/MS. These 283 
studies revealed global differences between both LAC and UAMS-1 and their isogenic sarA 284 
mutants (Supplementary Table 1). With respect to UAMS-1, a draft genome sequence has been 285 
published (37), but a fully annotated protein database is not yet available. Thus, based on our 286 
studies demonstrating that they are closely related strains (31), identification of UAMS-1 287 
proteins was based on comparisons to MRSA252. However, it should be noted that, while these 288 
two strains are closely related, they are not identical. For instance, MRSA252, like LAC, does 289 
not encode the gene for toxic shock syndrome toxin-1 (tst), which is present in UAMS-1 (31). 290 
Nevertheless, several particularly notable differences between LAC and UAMS-1 were 291 
identified (Table 1). For instance, they confirmed that, unlike LAC, UAMS-1 does not produce 292 
LukD/E, the Panton-Valentine leucocidin (PVL), or alpha toxin, all of which are potentially 293 
important virulence factors in the phenotypes we observed. However, LukD was present in 294 
increased amounts in a LAC sarA mutant relative to the parent strain, while LukE was detected 295 
at very low levels in both strains (Table 1). Similarly, PVL was also present in increased 296 
amounts in a LAC sarA mutant relative to its isogenic parent strain. This suggests that LukD/E 297 
or PVL are unlikely to contribute to the attenuation of a LAC sarA mutant. In contrast, alpha 298 
toxin was present in dramatically reduced amounts in a LAC sarA mutant (~11% compared to 299 
the isogenic parent strain). This suggests that alpha toxin could contribute to both the enhanced 300 
virulence of LAC relative to UAMS-1 and the reduced virulence of a LAC sarA mutant (24). 301 
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However, given its absence in UAMS-1, alpha toxin clearly does not contribute to the 302 
cytotoxicity or bone remodeling we observed with this strain.  303 
In general, these proteomics studies also confirmed our previous experiments (26) 304 
demonstrating that PSMs, specifically the alpha (α) class of PSMs, are present in increased 305 
levels in LAC relative to UAMS-1 and reduced levels in both LAC and UAMS-1 sarA mutants 306 
relative to the isogenic parent strains (Fig. 7 and Table 1). In fact, the amount of the α2 and α3 307 
PSMs was below the limit of detection in UAMS-1. Nevertheless, the differences observed 308 
between UAMS-1 and its sarA mutant did reach statistical significance with respect to α1 and 309 
α4, and statistically significant differences were observed between LAC and its sarA mutant with 310 
respect to all αPSMs (Fig. 7 and Table 1). These results are consistent with our previous 311 
experiments in which PSM levels were measured directly by HPLC (26). Moreover, previous 312 
studies employing a mutagenesis approach in LAC implicated αPSMs as key contributing 313 
factors to osteoblast cytotoxicity and bone remodeling in the same murine model we employed 314 
in the experiments reported here (23). 315 
Based on this, we examined the extent to which these peptides contribute to the 316 
phenotypes we observed in each parent strain. In both LAC and UAMS-1, mutation of the 317 
operon encoding αPSMs resulted in a significant decrease in cytotoxicity of both MC3T3-E1 318 
cells and RAW 264.7 cells (Fig 8). This effect appeared to be greater in LAC than in UAMS-1, 319 
particularly as assessed using MC3T3-E1 cells. Cytotoxicity was also significantly reduced in 320 
both LAC and UAMS-1 αPSM mutants when assessed using primary osteoblasts and 321 
osteoclasts, and when assessed using calvarial osteoblasts the impact of eliminating αPSM 322 
production was significantly greater in LAC than in UAMS-1 (Fig. 9). This is consistent with the 323 
observation that LAC produces PSMs at higher levels than UAMS-1 (26). Nevertheless, these 324 
results demonstrate that PSMs play an important role in mediating osteoblast and osteoclast 325 
cytotoxicity even in a strain like UAMS-1 that produces PSMs at relatively low levels, and they 326 
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suggest that the reduced accumulation of αPSMs may be a primary factor contributing to the 327 
reduced virulence of both LAC and UAMS-1 sarA mutants in our model.  328 
To address this, we used our murine osteomyelitis model to compare each parent strain 329 
and their αPSM mutants. The results confirmed that eliminating the production of alpha PSMs in 330 
LAC significantly reduced both the reactive new bone formation and cortical bone destruction 331 
observed in this model (Fig. 10). In contrast, neither of these parameters were significantly 332 
reduced in the UAMS-1 αPSM mutant in comparison to the isogenic parent strain. Thus, while 333 
these results suggest that PSMs play some role in the pathogenesis of acute, post-traumatic 334 
osteomyelitis even in strains like UAMS-1, they are likely to play a much more predominant role 335 
in defining USA300 strains like LAC. It is important to note in this regard that, while the results 336 
observed with sarA mutants in vitro in the context of cytotoxicity (Figs. 3-6) were consistent with 337 
those observed in vivo in the overall context of bone remodeling (Fig. 2), this was not the case 338 
with a UAMS-1 αPSM mutant (Figs. 8-10). This may be due to the fact that PSMs can be 339 
inactivated when bound by host lipoproteins (38), an effect that would presumably be more 340 
evident in a strain like UAMS-1 that produces PSMs at relatively low levels.   341 
The mechanistic basis for the role of PSMs in the pathogenesis of osteomyelitis also 342 
remains undetermined, but they are known to act as intracellular toxins that lyse osteoblasts, 343 
particularly in hypervirulent strains of S. aureus like LAC (5). PSMs have also been shown to 344 
induce the production of IL-8 (27), which in turn can promote osteoclast differentiation and 345 
activity (39). Taken together, these would presumably have the effect of increasing bone 346 
destruction by decreasing osteoblast activity while increasing osteoclast activity. It is difficult to 347 
envision how either would promote reactive bone formation, but it is noteworthy that this 348 
occurred at distinct sites distal to the inoculation site (Fig. 1). Together, these factors suggest 349 
the possibility that reactive bone formation is a downstream effect arising from the recruitment of 350 
osteoclasts to the site of infection and/or the systemic inflammatory response.  351 
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Finally, while our results demonstrate an important role for PSMs in the pathogenesis of 352 
osteomyelitis in LAC, they also suggest that other virulence factors play an important role both 353 
in defining the virulence of UAMS-1 and the attenuation of its isogenic sarA mutant. For 354 
instance, the fact that CM from a UAMS-1 αPSM mutant exhibited more cytotoxicity for primary 355 
osteoblasts than CM from a LAC αPSM mutant (Fig. 9) suggests that UAMS-1 produces a 356 
potentially relevant cytolytic factor that is either not produced by LAC or is produced in reduced 357 
amounts relative to a UAMS-1. Additionally, the fact that a UAMS-1 sarA mutant was less 358 
cytotoxic than a LAC sarA mutant (Figs. 3-6) suggests that the abundance of the relevant 359 
factor(s) is decreased in a UAMS-1 sarA mutant.  360 
One possibility is this regard are superantigens like TSST-1 and those encoded within the 361 
entertoxin gene cluster (egc), which are  produced by UAMS-1 but not LAC (40). However, 362 
while we did not detect TSST-1 in our proteomics analysis for the reasons discussed above, 363 
mutation of sarA has been shown to result in an increase in the production of TSST-1, albeit 364 
under in vitro conditions (41). One other possibility that does meet these criteria is protein A 365 
(Spa), which is present in both cell-associated and extracellular forms (42, 43) and was 366 
previously shown to bind to pre-osteoblastic cells via the TNFα receptor-1 resulting in apoptosis 367 
and ultimately bone loss (44). Thus, the fact that protein A was present in increased amounts in 368 
UAMS-1 relative to LAC (Spa in Table 1) could contribute to the virulence of UAMS-1 and the 369 
fact that eliminating PSM production in UAMS-1 had comparatively little impact in this model. 370 
The fact that the accumulation of Spa was reduced in a UAMS-1 sarA mutant could also 371 
account for why mutation of sarA had a comparable impact in both strains. At the same time, 372 
sarA mutants generated in both strains still caused bone destruction and new bone formation to 373 
a degree that exceeded that observed with the operative sham controls (Fig. 2). This is 374 
potentially important because it implicates virulence factors whose abundance is not impacted 375 
by mutation of sarA at the level of either their production or their accumulation. 376 
 377 
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FIGURE LEGENDS 528 
Fig. 1. Bone destruction and reactive bone formation in osteomyelitis as a function of 529 
sarA. C57BL/6 mice (n = 5) were infected with LAC, UAMS-1 (U1), or their isogenic sarA 530 
mutants (∆sarA). Femurs were harvested 14 days after inoculation and subjected to microCT 531 
imaging analysis. Antero-posterior views of infected femurs are shown for comparison. 532 
Fig. 2. Quantitative analysis of microCT imaging.  Images were analyzed for reactive new 533 
bone (callus) formation and cortical bone destruction in mice infected with LAC, UAMS-1 (U1), 534 
or their isogenic sarA mutants (∆sarA). Sham refers to results of the same analysis with mice 535 
subjected to the surgical procedure and injected with sterile PBS. Single asterisk denotes 536 
statistical significance compared to the sham. Double asterisks denote significance compared to 537 
the isogenic parent strain. 538 
Fig. 3. Cytotoxicity of LAC as assessed using established cell lines. MC3T3-E1 or RAW 539 
264.7 cells were exposed to conditioned medium (CM) from LAC, its sarA mutant (∆sarA), and 540 
its complemented sarA mutant (∆sarAC).  Viability was assessed after 24 hrs using Invitrogen 541 
LIVE calcien-AM staining (top) or fluorescence microscopy (bottom). Results of calcein-AM 542 
staining are reported as average mean fluorescence intensity (MFI) ± the standard deviation. 543 
Single asterisk denotes statistical significance compared to the results observed with the 544 
isogenic parent strain. Double asterisks denote significance compared to the results observed 545 
with the isogenic sarA mutant.   546 
Fig. 4. Cytotoxicity of UAMS-1 as assessed using established cell lines. MC3T3-E1 or 547 
RAW 264.7 cells were exposed to conditioned medium (CM) from the UAMS-1 (U1), its sarA 548 
mutant (∆sarA), and its complemented sarA mutant (∆sarAC). Viability was assessed after 24 549 
hrs using Invitrogen LIVE calcien-AM staining (top) or fluorescence microscopy (bottom). 550 
Results of calcein-AM staining are reported as average mean fluorescence intensity (MFI) ± the 551 
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standard deviation. Single asterisk denotes statistical significance compared to the results 552 
observed with the isogenic parent strain. Double asterisks denote significance compared to the 553 
results observed with the isogenic sarA mutant.   554 
Fig. 5. Cytotoxicity of conditioned medium for primary osteoblasts. Primary osteoblast 555 
cells were exposed to conditioned medium (CM) from the indicated strains and viability 556 
assessed after 24 hrs using Invitrogen LIVE calcien-AM staining (top) or fluorescence 557 
microscopy (bottom). Results of calcein-AM staining are reported as average mean 558 
fluorescence intensity (MFI) ± the standard deviation. Single asterisk denotes statistical 559 
significance compared to the results observed with the isogenic parent strain. 560 
Fig. 6. Cytotoxicity of conditioned medium for primary osteoclasts. Primary bone marrow-561 
derived murine osteoclasts were exposed to CM from the indicated strains. After 12 hrs, viability 562 
was assessed by TRAP staining (inset TRAP+ multinucleated cells), with the graph 563 
representing quantitative analysis of all replicates. Single asterisk denotes statistical 564 
significance compared to the results observed with the isogenic parent strain. 565 
Fig. 7. Alpha PSM levels as assessed by GeLC-MS/MS. Black bars represent the amount of 566 
the indicated PSM produced by LAC or UAMS-1. Gray bars represent amounts observed in the 567 
isogenic sarA mutants. Asterisk indicates a statistically significant difference for the indicated 568 
peptide compared to the amount of the same peptide observed in the isogenic parent strain. 569 
Fig. 8. Cytotoxicity in established cell lines as a function of PSM production. MC3T3-E1 or 570 
RAW 264.7 cells were exposed to CM from LAC, UAMS-1 (U1), their isogenic αpsm mutants 571 
(∆psmα), and complemented psm mutants (∆psmαC). Viability was assessed after 24 hrs using 572 
Invitrogen LIVE calcien-AM staining (top) or fluorescence microscopy (bottom). Results of 573 
calcein-AM staining are reported as average mean fluorescence intensity (MFI) ± the standard 574 
deviation. Single asterisk denotes statistical significance compared to the results observed with 575 
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the isogenic parent strain. Double asterisks denote significance compared to the results 576 
observed with isogenic psm mutant.    577 
Fig. 9. Impact of PSMs on cytotoxicity for primary osteoblasts and osteoclasts. Primary 578 
osteoblast cells were exposed to CM from the indicated strains. Viability was assessed after 24 579 
hrs using Invitrogen LIVE calcien-AM staining (top) or fluorescence microscopy (bottom). 580 
Results of calcein-AM staining are reported as average mean fluorescence intensity (MFI) ± the 581 
standard deviation. Primary bone marrow-derived murine osteoclasts were exposed to CM from 582 
the indicated strains. After 12 hrs, viability was assessed by TRAP staining with the graph 583 
representing quantitative analysis of all replicates. Single asterisk denotes statistical 584 
significance compared to the results observed with the isogenic parent strain in both cell types. 585 
Fig. 10. Impact of PSMs as assessed by microCT. Images were analyzed for reactive new 586 
bone (callus) formation and cortical bone destruction in mice infected with LAC, UAMS-1 (U1), 587 
or their isogenic αPSM (∆psmα) mutants. Sham refers to results of the same analysis with mice 588 
subjected to the surgical procedure and injected with sterile PBS. Single asterisk denotes 589 
statistical significance compared to the sham. Double asterisks denote significance compared to 590 
the isogenic parent strain.  591 
Table 1. Impact of sarA and proteases on abundance of select S. aureus proteins. 592 
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Table 1. Relative production of select proteins in LAC, UAMS-1, and their isogenic sarA 
mutants. 
Protein LAC sarA UAMS-1 sarA 
α toxin 1019 117 0 0 
PVL (LukF) 324 2292 0 0 
PVL (LukS) 229 1458 0 0 
LukD 104 576 0 0 
LukE 23 3 0 0 
PSMα1 102 15 56 13 
PSMα2 32 0 0 0 
PSMα3 12 0 0 0 
PSMα4 112 5 64 14 
Δ toxin 159 40 317 83 
Spa 903 1 1379 29 
Results reflect the average number of spectral counts from triplicate samples as assessed by 
GeLC-MS/MS. 
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